Framework agreement for the supply of antineoplastic medicines

Summary

The procurement concerns a two-year framework agreement for the supply of medicines for the PN Oncology programme, including antineoplastic medicines. The estimated contract value is EUR 54,066,774.24, and the tender deadline is 31 August 2026 at 00:00. Interested economic operators may request clarifications until 18 days before the tender submission deadline; the contracting authority will respond by the 11th day before that deadline. The machine-readable notice did not provide precise bidder qualification or compliance requirements, so these must be checked in the official tender documents.